The invention provides for novel MAP kinase inhibitors and compositions comprising the same. In some embodiments, the MAP kinase inhibitors are p38a MAP kinase inhibitors. The invention further provides for methods for treatment of diseases comprising administration of MAP kinase inhibitors or compositions comprising MAP kinase inhibitors. In some embodiments, the disease is Alzheimer's Disease, ALS, Huntington's Disease or Parkinson's Disease.
本发明提供了新型
MAP 激酶
抑制剂和包含这些
抑制剂的组合物。在某些实施方案中,
MAP 激酶
抑制剂是 p38a
MAP 激酶
抑制剂。本发明进一步提供了治疗疾病的方法,包括给予
MAP 激酶
抑制剂或包含
MAP 激酶
抑制剂的组合物。在一些实施方案中,疾病是阿尔茨海默病、渐冻人症、亨廷顿氏病或帕
金森氏病。